Access cutting-edge dementia treatment through this clinical trial at a research site in Bloomington. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Bloomington location
Preparing your pre-screening questions…
Access dementia specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related dementia treatment provided free
Check if you qualify for this dementia clinical trial in Bloomington, IN
No-Cost Study Care
Local to Bloomington
Convenient for IN residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Cognitive impairment related to dementia is frequently under-diagnosed in primary care settings. This problem is more prevalent in health disparities populations. The investigators developed the 5-Cog brief cognitive assessment that is simple to use, standardized, takes \<5 minutes, does not require informants, and accounts for major technical, cultural, and logistical barriers of current assessments. The investigators propose a hybrid Type 1 effectiveness-implementation design in real-world settings to adapt and test the effectiveness of the 5-Cog paradigm to increase detection of cognitive impairment care in older adults presenting with cognitive concerns. The study aim is to evaluate, using a pragmatic cluster-randomized trial design, the effectiveness of the 5-Cog paradigm to increase 'incident cognitive impairment' detection (new MCI and dementia diagnoses) relative to enhanced usual care in 6,600 older patients presenting with cognitive concerns in 22 primary care clinics in Bronx and Indiana. As diagnosis without action will not improve patient care, 'improved dementia care' will be examined as a secondary outcome. Results will also be examined in NIH designated health disparity populations including underserved minority and socio-economically challenged populations.
Sponsor: Albert Einstein College of Medicine
Yes, this clinical trial (NCT05515224) has an active research site in Bloomington, IN that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for dementia treatment options in Bloomington, IN, this clinical trial (NCT05515224) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Bloomington research site is actively enrolling participants for this clinical trial. You'll receive care from experienced dementia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all dementia clinical trials near you to find additional studies recruiting in your area.
See all alzheimers disease clinical trials recruiting in Bloomington — not just this study.
Browse Alzheimers Disease Trials in Bloomington →